Use of raw data in medicine evaluation
Submitted by Anonymous (not verified) on 24 July 2024 - 14:38
Use of raw data in medicine evaluation
Human medicines European public assessment report (EPAR): DuoResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2024 - 14:26
Human medicines European public assessment report (EPAR): DuoResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): BiResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2024 - 14:26
Human medicines European public assessment report (EPAR): BiResp Spiromax, budesonide,formoterol, Date of authorisation: 28/04/2014, Revision: 13, Status: Authorised
HMA-EMA joint Big Data Steering Group
Submitted by Anonymous (not verified) on 24 July 2024 - 14:18
HMA-EMA joint Big Data Steering Group
Big Data Steering Group
Submitted by Anonymous (not verified) on 24 July 2024 - 14:18
Big Data Steering Group
European Medicines Agency (EMA) Healthcare Professionals' (HCPWP) Working Party meeting, European Medicines Agency, Amsterdam, the Netherlands, 3 July 2024
Submitted by Anonymous (not verified) on 24 July 2024 - 13:19
European Medicines Agency (EMA) Healthcare Professionals' (HCPWP) Working Party meeting, European Medicines Agency, Amsterdam, the Netherlands, 3 July 2024
Meeting summary - Patients and Consumers Working Party (PCWP) and Healthcare Professionals Working Party (HCPWP) meeting (2-3 July 2024)
Submitted by Anonymous (not verified) on 24 July 2024 - 13:18
Meeting summary - Patients and Consumers Working Party (PCWP) and Healthcare Professionals Working Party (HCPWP) meeting (2-3 July 2024)
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) Working Party meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 July 2024
Submitted by Anonymous (not verified) on 24 July 2024 - 13:17
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) Working Party meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 July 2024
Meeting summary - Patients and Consumers Working Party (PCWP) meeting (2 July 2024)
Submitted by Anonymous (not verified) on 24 July 2024 - 13:15
Meeting summary - Patients and Consumers Working Party (PCWP) meeting (2 July 2024)
Human medicines European public assessment report (EPAR): Teriflunomide Mylan, teriflunomide, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2024 - 11:53
Human medicines European public assessment report (EPAR): Teriflunomide Mylan, teriflunomide, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised